Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/2612
Title: | Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery |
Authors: | Marques, Joana Valle-Delgado, Juan José Urbán, Patricia Baró, Elisabet Prohens, Rafel Mayor, Alfredo Cisteró, Pau Delves, Michael Sinden, Robert E Grandfils, Christian de Paz, José L García-Salcedo, José A Fernàndez-Busquets, Xavier |
metadata.dc.contributor.authoraffiliation: | [Marques,J; Valle-Delgado,JJ; Urbán,P; Baró,E; Fernàndez-Busquets,X] Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain. Barcelona Institute for Global Health (ISGlobal), Barcelona Center for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain. Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Barcelona, Spain. [Prohens,R] Unitat de Polimorfisme i Calorimetria, Centres Científics i Tecnològics, Universitat de Barcelona, Barcelona, Spain. [Mayor,A; Cisteró,P] Barcelona Institute for Global Health (ISGlobal), Barcelona Center for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain. [Delves,M; Sinden,RE] Department of Life Sciences, Imperial College, South Kensington, London, UK. [Grandfils,C] Interfacultary Research Center of Biomaterials (CEIB), University of Liège, Chemistry Institute, Liège (Sart-Tilman), Belgium. [de Paz,JL] Instituto de Investigaciones Químicas (IIQ) CSIC-US, Centro de Investigaciones Científicas Isla de La Cartuja, Sevilla, Spain. [García-Salcedo,JA] Unidad de Enfermedades Infecciosas y Microbiología, Instituto de Investigación Biosanitaria ibs. Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. |
Keywords: | Glycosaminoglycans;Malaria;Nanomedicine;Plasmodium;Targeted drug delivery;Quitosano;Recuento de eritrocitos;Antimaláricos;Insectos vectores;Heparina |
metadata.dc.subject.mesh: | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiparasitic Agents::Antiprotozoal Agents::Antimalarials Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Polysaccharides::Chitin::Chitosan Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Polysaccharides::Glycosaminoglycans::Chondroitin::Chondroitin Sulfates Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Erythrocyte Count Medical Subject Headings::Anatomy::Hemic and Immune Systems::Blood::Blood Cells::Erythrocytes Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Polysaccharides::Glycosaminoglycans::Heparin Medical Subject Headings::Chemicals and Drugs::Lipids Medical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Dosage Forms::Drug Carriers::Liposomes Medical Subject Headings::Diseases::Parasitic Diseases::Protozoan Infections::Malaria Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Transmission, Infectious::Disease Vectors::Arthropod Vectors::Insect Vectors::Mosquito Vectors Medical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Manufactured Materials::Nanostructures::Nanoparticles Medical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Nanotechnology Medical Subject Headings::Organisms::Eukaryota::Alveolata::Apicomplexa::Haemosporida::Plasmodium Medical Subject Headings::Organisms::Eukaryota::Animals |
Issue Date: | Feb-2017 |
Publisher: | Elsevier |
Citation: | Marques J, Valle-Delgado JJ, Urbán P, Baró E, Prohens R, Mayor A et al.Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery. Nanomedicine. 2017 Feb;13(2):515-525 |
Abstract: | The adaptation of existing antimalarial nanocarriers to new Plasmodium stages, drugs, targeting molecules, or encapsulating structures is a strategy that can provide new nanotechnology-based, cost-efficient therapies against malaria. We have explored the modification of different liposome prototypes that had been developed in our group for the targeted delivery of antimalarial drugs to Plasmodium-infected red blood cells (pRBCs). These new models include: (i) immunoliposome-mediated release of new lipid-based antimalarials; (ii) liposomes targeted to pRBCs with covalently linked heparin to reduce anticoagulation risks; (iii) adaptation of heparin to pRBC targeting of chitosan nanoparticles; (iv) use of heparin for the targeting of Plasmodium stages in the mosquito vector; and (v) use of the non-anticoagulant glycosaminoglycan chondroitin 4-sulfate as a heparin surrogate for pRBC targeting. The results presented indicate that the tuning of existing nanovessels to new malaria-related targets is a valid low-cost alternative to the de novo development of targeted nanosystems. |
Description: | Patent application: Heparin-lipidic nanoparticle conjugates. Inventors: Fernàndez-Busquets, X., Marques, J., Moles, E. Institutions: IBEC, ISGlobal. Application number: EP13152187.4; priority country: Europe; priority date: January 22, 2013. |
URI: | http://hdl.handle.net/10668/2612 |
metadata.dc.relation.publisherversion: | http://www.sciencedirect.com/science/article/pii/S1549963416301629 |
metadata.dc.identifier.doi: | 10.1016/j.nano.2016.09.010 |
ISSN: | 1549-9634 (Print) 1549-9642 (Online) |
Appears in Collections: | 01- Artículos - Complejo Hospitalario Universitario de Granada 01- Artículos - ibsGRANADA. Instituto de Investigación Biosanitaria de Granada |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Marques_AdaptationOfTargetedNanocarriers.pdf | Artículo publicado | 1,47 MB | Adobe PDF | View/Open |
Marques_AdaptationOfTargetedsNanocarriersVideo.mp4 | Material suplementario | 2,95 MB | Audio Video Interleave File | View/Open |
Marques_AdaptationOfTargetedNanocarriersSuppl.pdf | Material suplementario | 1,04 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License